TRIEU VUONG (CEO and Chairman of the Board) purchased 0.4% of their position (335.76K shares) of ONCOTELIC THERAPEUTICS, INC. on the open market
Open‑market purchase worth $15.0K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 6/17/2026ACC: 0001493152-26-029137
DirectorOfficer10% Owner· CEO and Chairman of the Board
Since Apr 2019
+335.76K
Net shares
Net buyer
$15.0K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
335.76K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+96K
Price / share
$0.04
Trade value
$4.32K
% of position
0.1%
6/15/2026
93.29M→93.39M
Common Stock
Direct
Shares
+239.76K
Price / share
$0.04
Trade value
$10.69K
% of position
0.3%
6/17/2026
93.39M→93.63M
Total
Net shares
+335.76K
Net value
$15.01K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/15/2026 | P · Purchase | +96K | $0.04 | $4.32K | 0.1% | 93.29M | 93.39M |
| Common Stock Direct | 6/17/2026 | P · Purchase | +239.76K | $0.04 | $10.69K | 0.3% | 93.39M | 93.63M |
| Total | +335.76K | $15.01K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned16.78M
Common Stock
IndirectShares owned6.87M
Total
23.65M indirect23.65M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 16.78M | Indirect |
| Common Stock | 6.87M | Indirect |
| Total | 23.65M | 23.65M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported